|
 | David A. GassPartner Marshall, Gerstein & Borun LLP
Sears Tower 6300, 233 South Wacker Drive
Chicago, Illinois
60606-6357
(Cook Co.)
Telephone: 312-474-6300
Fax: 312-474-0448
http://www.marshallip.com
|
Profile Visibility  | | #5,125 in weekly profile views out of 25,776 lawyers in Chicago, Illinois | | #249,733 in weekly profile views out of 968,939 total lawyers Overall |
|
|
| |
| Practice Areas | Intellectual Property; Patent Interference Practice; Pharmaceutical Intellectual Property; Nanotechnology; Biotechnology; Intellectual Property Portfolio Management; Patent Prosecution | | | Education | Boalt Hall School of Law, University of California, J.D., 1992, University of Michigan, B.S., Cellular/Molecular Biology, with highest honors/highest distinction, 1988 | | | Admitted | 1992, Illinois; U.S. District Court, Northern District of Illinois; registered to practice before U.S. Patent and Trademark Office | |
| Memberships | American Bar Association; Intellectual Property Law Association of Chicago. | | | Biography | David A. Gass performs domestic and international patent prosecution, with a particular emphasis in biotechnology-related matters. His patent law experience includes interference proceedings before the U.S. Patent and Trademark Office and advising foreign counsel in foreign patent prosecution and opposition proceedings. Mr. Gass also counsels clients concerning all aspects of intellectual property as they relate to business strategies and patent life cycle management, and prepares opinions directed to patent validity, infringement, and freedom to operate. Mr. Gass assists clients with the negotiation and drafting of licenses and other agreements pertaining to patent, trademark, copyright, and other intellectual property rights. Mr. Gass has handled matters in a wide variety of biotechnology disciplines, such as: recombinant DNA, protein, and antibody technologies; genomics and proteomics; recombinant growth factors, enzymes, chemokines, and cell surface receptors; angiogenesis and anti-angiogenesis technologies and circulatory disorders; gene therapy, interfering RNA, and antisense technologies; genetic engineering of plants and animals; cancer and oncogenes; polymerase chain reaction and mass spectrometry; nanotechnology and industrial biopolymers; transgenic organisms; prions, Alzheimer's disease, and neural regeneration; inflammation and arthritis; therapeutic methodologies and formulations; medical diagnostics and kits that involve both traditional and genetic methodologies; food and beverage formulations; and restriction endonuclease reactions. Prior to attending law school, Mr. Gass worked for two years at the University of Michigan as a researcher studying plant mitochondrial genetics. Author: "An Analysis of Decisional Law Governing the Use of DNA Evidence," in DNA On Trial - Genetic Identification and Criminal Justice, ed. Paul R. Billings, Cold Spring Harbor Press, 1992; "Variable Intron Content of the NADH Dehydrogenase Subunit 4 Gene of Plant Mitochondria," Curr. Genet. 21:423-430 (1992). | | | ISLN | 901147002 | |
|
|
RSS | Blog | Advertising Opportunities | Site Map | Contact Us
